201 related articles for article (PubMed ID: 32565008)
21. Most families tend to realize progress of Alzheimer's disease when behavioural and psychological symptoms are obvious.
Honjo Y; Ide K; Takechi H
Psychogeriatrics; 2022 May; 22(3):317-323. PubMed ID: 35146847
[TBL] [Abstract][Full Text] [Related]
22. A randomized, double-blind, placebo-controlled trial of modafinil for the treatment of apathy in individuals with mild-to-moderate Alzheimer's disease.
Frakey LL; Salloway S; Buelow M; Malloy P
J Clin Psychiatry; 2012 Jun; 73(6):796-801. PubMed ID: 22687392
[TBL] [Abstract][Full Text] [Related]
23. Methylphenidate for the treatment of apathy in Alzheimer disease: prediction of response using dextroamphetamine challenge.
Herrmann N; Rothenburg LS; Black SE; Ryan M; Liu BA; Busto UE; Lanctôt KL
J Clin Psychopharmacol; 2008 Jun; 28(3):296-301. PubMed ID: 18480686
[TBL] [Abstract][Full Text] [Related]
24. Quality of Life in relation to neuropsychiatric symptoms in Alzheimer's disease: 5-year prospective ALSOVA cohort study.
Hongisto K; Hallikainen I; Selander T; Törmälehto S; Väätäinen S; Martikainen J; Välimäki T; Hartikainen S; Suhonen J; Koivisto AM
Int J Geriatr Psychiatry; 2018 Jan; 33(1):47-57. PubMed ID: 28067961
[TBL] [Abstract][Full Text] [Related]
25. Neuropsychiatric symptoms and subsyndromes in patients with different stages of dementia in primary care follow-up (NeDEM project): a cross-sectional study.
García-Martín V; de Hoyos-Alonso MC; Ariza-Cardiel G; Delgado-Puebla R; García-Domingo P; Hernández-Melo E; de Haro-de Torres JL; Del Cura-González I
BMC Geriatr; 2022 Jan; 22(1):71. PubMed ID: 35065615
[TBL] [Abstract][Full Text] [Related]
26. Neurobiologic Rationale for Treatment of Apathy in Alzheimer's Disease With Methylphenidate.
van Dyck CH; Arnsten AFT; Padala PR; Brawman-Mintzer O; Lerner AJ; Porsteinsson AP; Scherer RW; Levey AI; Herrmann N; Jamil N; Mintzer JE; Lanctôt KL; Rosenberg PB
Am J Geriatr Psychiatry; 2021 Jan; 29(1):51-62. PubMed ID: 32461027
[TBL] [Abstract][Full Text] [Related]
27. [Japanese version of the Neuropsychiatric Inventory--a scoring system for neuropsychiatric disturbance in dementia patients].
Hirono N; Mori E; Ikejiri Y; Imamura T; Shimomura T; Hashimoto M; Yamashita H; Ikeda M
No To Shinkei; 1997 Mar; 49(3):266-71. PubMed ID: 9125732
[TBL] [Abstract][Full Text] [Related]
28. Course of neuropsychiatric symptoms in dementia: 5-year longitudinal study.
Vik-Mo AO; Giil LM; Ballard C; Aarsland D
Int J Geriatr Psychiatry; 2018 Oct; 33(10):1361-1369. PubMed ID: 29979473
[TBL] [Abstract][Full Text] [Related]
29. Effects of anosognosia and neuropsychiatric symptoms on the quality of life of patients with Alzheimer's disease: a 24-month follow-up study.
Conde-Sala JL; Turró-Garriga O; Piñán-Hernández S; Portellano-Ortiz C; Viñas-Diez V; Gascón-Bayarri J; Reñé-Ramírez R
Int J Geriatr Psychiatry; 2016 Feb; 31(2):109-19. PubMed ID: 25963296
[TBL] [Abstract][Full Text] [Related]
30. Bupropion for the Treatment of Apathy in Alzheimer Disease: A Randomized Clinical Trial.
Maier F; Spottke A; Bach JP; Bartels C; Buerger K; Dodel R; Fellgiebel A; Fliessbach K; Frölich L; Hausner L; Hellmich M; Klöppel S; Klostermann A; Kornhuber J; Laske C; Peters O; Priller J; Richter-Schmidinger T; Schneider A; Shah-Hosseini K; Teipel S; von Arnim CAF; Wiltfang J; Jessen F
JAMA Netw Open; 2020 May; 3(5):e206027. PubMed ID: 32463470
[TBL] [Abstract][Full Text] [Related]
31. The effects of behavioral and psychological symptoms on caregiver burden in frontotemporal dementia, Lewy body dementia, and Alzheimer's disease: clinical experience in China.
Liu S; Jin Y; Shi Z; Huo YR; Guan Y; Liu M; Liu S; Ji Y
Aging Ment Health; 2017 Jun; 21(6):651-657. PubMed ID: 26882509
[TBL] [Abstract][Full Text] [Related]
32. Changes in Neuropsychiatric Inventory Associated with Semagacestat Treatment of Alzheimer's Disease.
Rosenberg PB; Lanctôt KL; Herrmann N; Mintzer JE; Porsteinsson AP; Sun X; Raman R
J Alzheimers Dis; 2016 Aug; 54(1):373-81. PubMed ID: 27567808
[TBL] [Abstract][Full Text] [Related]
33. Neuropsychiatric symptoms and brain morphology in patients with mild cognitive impairment and Alzheimer's disease with dementia.
Siafarikas N; Alnæs D; Monereo-Sanchez J; Lund MJ; Selbaek G; Stylianou-Korsnes M; Persson K; Barca ML; Almdahl IS; Fladby T; Aarsland D; Andreassen OA; Westlye LT
Int Psychogeriatr; 2021 Nov; 33(11):1217-1228. PubMed ID: 34399870
[TBL] [Abstract][Full Text] [Related]
34. Characteristics of behavioral symptoms in right-sided predominant semantic dementia and their impact on caregiver burden: a cross-sectional study.
Sato S; Hashimoto M; Yoshiyama K; Kanemoto H; Hotta M; Azuma S; Suehiro T; Kakeda K; Nakatani Y; Umeda S; Fukuhara R; Takebayashi M; Ikeda M
Alzheimers Res Ther; 2021 Oct; 13(1):166. PubMed ID: 34627361
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic criteria for apathy in clinical practice.
Mulin E; Leone E; Dujardin K; Delliaux M; Leentjens A; Nobili F; Dessi B; Tible O; Agüera-Ortiz L; Osorio RS; Yessavage J; Dachevsky D; Verhey FR; Cruz Jentoft AJ; Blanc O; Llorca PM; Robert PH
Int J Geriatr Psychiatry; 2011 Feb; 26(2):158-65. PubMed ID: 20690145
[TBL] [Abstract][Full Text] [Related]
36. Apathy correlates with prefrontal amyloid β deposition in Alzheimer's disease.
Mori T; Shimada H; Shinotoh H; Hirano S; Eguchi Y; Yamada M; Fukuhara R; Tanimukai S; Zhang MR; Kuwabara S; Ueno S; Suhara T
J Neurol Neurosurg Psychiatry; 2014 Apr; 85(4):449-55. PubMed ID: 24133289
[TBL] [Abstract][Full Text] [Related]
37. [A longitudinal study of apathy in patients with Alzheimer's disease].
Turró-Garriga O; López-Pousa S; Vilalta-Franch J; Turón-Estrada A; Pericot-Nierga I; Lozano-Gallego M; Hernández-Ferràndiz M; Soler-Cors O; Planas-Pujol X; Monserrat-Vila S; Garre-Olmo J
Rev Neurol; 2009 Jan 1-15; 48(1):7-13. PubMed ID: 19145559
[TBL] [Abstract][Full Text] [Related]
38. The efficacy of nonpharmacological treatment for dementia-related apathy.
Ferrero-Arias J; Goñi-Imízcoz M; González-Bernal J; Lara-Ortega F; da Silva-González A; Díez-Lopez M
Alzheimer Dis Assoc Disord; 2011; 25(3):213-9. PubMed ID: 21346517
[TBL] [Abstract][Full Text] [Related]
39. Reliability of the Brazilian Portuguese version of the Neuropsychiatric Inventory (NPI) for patients with Alzheimer's disease and their caregivers.
Camozzato AL; Kochhann R; Simeoni C; Konrath CA; Pedro Franz A; Carvalho A; Chaves ML
Int Psychogeriatr; 2008 Apr; 20(2):383-93. PubMed ID: 18257965
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of Transcranial Direct Current Stimulation Combined with Cognitive Training in the Treatment of Apathy in Patients with Alzheimer's Disease: Study Protocol for a Randomized Trial.
Nguyen JP; Boutoleau-Bretonniere C; Lefaucheur JP; Suarez A; Gaillard H; Chapelet G; Abad S; Van Langhenhove A; Nizard J; de Decker L
Rev Recent Clin Trials; 2018; 13(4):319-327. PubMed ID: 29658441
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
